S-phase Inhibition of Cell Cycle Progression by a Novel Class of Pyridopyrimidine Tyrosine Kinase Inhibitors

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cell Cycle

• Publication date

  2004-04-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4161/cc.3.6.899PMID 15136770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cycling without Cyclins

  2004cited by this paper
• Mammalian Cell Cycles without Cyclin E-CDK2

  2004cited by this paper
• A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.

  2003cited by this paper
• A fluorescence polarization assay for native protein substrates of kinases.

  2003cited by this paper
• Mitotic Regulation of Ribosomal S6 Kinase 1 Involves Ser/Thr, Pro Phosphorylation of Consensus and Non-consensus Sites by Cdc2*

  2003cited by this paper
• Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition

  2002cited by this paper
• Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.

  2002cited by this paper
• Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

  2002cited by this paper
• Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

  2002cited by this paper
• Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest

  2002cited by this paper
• Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control

  2002cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• Activation of mammalian Chk1 during DNA replication arrest

  2001cited by this paper
• Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes.

  2001cited by this paper
• Differential Regulation of Cdc2 and Cdk2 by RINGO and Cyclins* 210

  2001cited by this paper
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• S and G2 Phase Roles for Cdk2 Revealed by Inducible Expression of a Dominant-Negative Mutant in Human Cells

  2001cited by this paper
• Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers.

  2001cited by this paper
• Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population.

  2000cited by this paper
• STAT signaling in head and neck cancer

  2000cited by this paper
• Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.

  2000influential reference
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.

  2000cited by this paper
• c-Src, receptor tyrosine kinases, and human cancer.

  1999cited by this paper
• Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.

  1999cited by this paper
• Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530

  1999influential reference
• DNA Damage and Replication Checkpoints in Fission Yeast Require Nuclear Exclusion of the Cdc25 Phosphatase via 14-3-3 Binding

  1999cited by this paper
• Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site

  1999cited by this paper
• Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.

  1998cited by this paper
• Replication checkpoint enforced by kinases Cds1 and Chk1.

  1998cited by this paper
• Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non‐consensus sites

  1998cited by this paper
• Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

  1998cited by this paper
• Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity*

  1997cited by this paper
• Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.

  1997cited by this paper
• The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex

  1997cited by this paper
• Cyclin-dependent kinases: engines, clocks, and microprocessors.

  1997cited by this paper
• Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases*

  1997cited by this paper
• Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation

  1997cited by this paper
• Viewpoint: Putting the Cell Cycle in Order

  1996cited by this paper
• Active and inactive protein kinases: structural basis for regulation.

  1996cited by this paper
• Regulation of Cdc2 activity by phosphorylation at T14/Y15.

  1996cited by this paper
• rad-Dependent Response of the chk1-Encoded Protein Kinase at the DNA Damage Checkpoint

  1996cited by this paper
• c‐Src PROTEIN EXPRESSION IS INCREASED IN HUMAN BREAST CANCER. AN IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSIS

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Regulation of the human WEE1Hu CDK tyrosine 15‐kinase during the cell cycle.

  1995cited by this paper
• Cyclin dependent kinase regulation.

  1995cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Cell cycle regulation of human WEE1.

  1995cited by this paper
• Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division.

  1995cited by this paper
• Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15

  1995cited by this paper
• Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle

  1995cited by this paper
• Cyclins and cyclin-dependent kinases: a biochemical view.

  1995cited by this paper
• Ordering S phase and M phase in the cell cycle.

  1994cited by this paper
• Cdc2 regulatory factors.

  1994cited by this paper
• Mitosis in transition.

  1994cited by this paper
• Premature p34cdc2 activation required for apoptosis.

  1994cited by this paper
• Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

  1993cited by this paper
• Activation of the various cyclin/cdc2 protein kinases.

  1993cited by this paper
• The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.

  1993cited by this paper
• The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin‐dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues.

  1993cited by this paper
• Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

  1993influential reference
• The cdk2 kinase is required for the G1-to-S transition in mammalian cells.

  1993cited by this paper
• Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.

  1992cited by this paper
• The cdc25 M-phase inducer: an unconventional protein phosphatase.

  1992cited by this paper
• Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

  1992cited by this paper
• Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes.

  1991cited by this paper
• Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein

  1991cited by this paper
• Immunolocalization of the cellular src protein in interphase and mitotic NIH c-src overexpresser cells

  1990cited by this paper
• Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements.

  1990cited by this paper
• Checkpoints: controls that ensure the order of cell cycle events.

  1989cited by this paper
• Altered phosphorylation and activation of pp60c-src during fibroblast mitosis.

  1988cited by this paper

• Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders

  2023cites this paper
• Design, Synthesis and Antibacterial Studies of Some New Pyridopyrimidine Derivatives as Biotin Carboxylase Inhibitors

  2021cites this paper
• Synthesis, characterization and molecular docking studies on some new N-substituted 2-phenylpyrido[2,3-d]pyrimidine derivatives

  2021cites this paper
• Structure-activity relationships of Wee1 inhibitors: A review.

  2020cites this paper
• Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells

  2017cites this paper
• Cisplatin Resistance in Malignant Pleural Mesothelioma

  2012cites this paper
• New pyrazolo‐[3,4‐d]‐pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells

  2010cites this paper
• Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells.

  2009cites this paper
• Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells

  2009cites this paper
• To C or not to C: Direct and indirect redox regulation of Src protein tyrosine kinase

  2009cites this paper
• Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.

  2009cites this paper
• 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.

  2008cites this paper
• Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.

  2007cites this paper
• Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells

  2007cites this paper
• Mechanism of impaired regeneration of fatty liver in mouse partial hepatectomy model

  2007cites this paper
• Aberrations of DNA Damage in Checkpoints in Cancer

  2007cites this paper
• 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution.

  2006cites this paper
• A facile synthesis of new tetrahydropyrido[4,3-d]pyrimidine derivatives

  2006cites this paper
• EGF Induces Cell Motility and Multi-Drug Resistance Gene Expression in Breast Cancer Cells

  2006cites this paper
• Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line

  2006cites this paper
• Adhesion signaling by a novel mitotic substrate of src kinases

  2005cites this paper